Peer-influenced content. Sources you trust. No registration required. This is HCN.
News Medical
Researchers found that antibodies from Kawasaki disease patients consistently recognized viral inclusion bodies in medium-sized airways across all examined tissue samples spanning five decades and two continents, strongly suggesting a single predominant respiratory virus as the causative agent.
Allergy & Immunology May 8th 2025
Journal of the American College of Cardiology (JACC)
Registry data shows that comorbidities not captured in traditional surgical risk scores, particularly atrial fibrillation and poor baseline functional status, significantly impact post-TAVR outcomes in low-risk patients.
Cardiology May 6th 2025
Cath Lab Digest
DETECT AS trial showed electronic notifications increased AVR rates by 11% overall and 14% in symptomatic patients, while EARLY TAVR analyses confirmed superior outcomes with timely intervention versus surveillance, with biomarkers failing to predict optimal treatment timing.
Epoch Health
The article presents evidence suggesting cardiovascular risk may correlate more strongly with inflammatory processes than cholesterol levels, recommending CRP monitoring alongside comprehensive biomarker assessment and lifestyle modifications targeting inflammation reduction through carbohydrate restriction.
GoodRx for Healthcare Professionals
Joint and muscle pain are established side effects across multiple medication classes including antibiotics, cholesterol-lowering agents, and cancer therapies, with varying onset timing, risk factors, and management approaches that clinicians should recognize to optimize treatment adherence.
MedCentral
The study identifies three scenarios where CAC testing provides limited value: “too early” (younger patients without risk factors), “too late” (elderly patients or those already on statins), and “too often” (repeated imaging after statin initiation).